Optimizing Diagnostics And Therapy Of Arrhythmia And Syncope Events Using Intelligent Telemetric Solutions. Diagnostics Of Arrhythmia In Children
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Arrhythmia
- Sponsor
- National Institute of Cardiology, Warsaw, Poland
- Enrollment
- 400
- Locations
- 3
- Primary Endpoint
- Recording of symptomatic or life threatening arrhythmia event
- Last Updated
- 14 years ago
Overview
Brief Summary
The purpose of this study is to assess efficacy of prolonged Full Disclosure electrocardiogram (ECG) monitoring and signal analysis using advanced telemetric technology to diagnose arrhythmia in comparison with standard diagnostic procedure.
Detailed Description
Irregular and/or rapid beating of the heart called heart palpitations can occur in individuals without heart disease and the reasons for their palpitations are unknown. Together with heart palpitations silent arrhythmia may be present that could lead to serious complications (eg. stroke). In others, palpitations result from heart rhythm disturbances, sometimes life threatening. Standard diagnostic methods such as 24 hours Holter electrocardiogram (ECG) monitoring or Event Holter do not guarantee early diagnosis of the arrhythmia. Prolonged heart rhythm recording and analysis using an automatic full disclosure telemetric device can increase probability of arrhythmia diagnosis and early administration of applicable treatment. Study patients will be diagnosed using standard Holter ECG monitoring, Event Holter or 30 days telemetric ECG monitoring. Efficacy of telemetric monitoring in diagnosis of cardiac arrhythmia will be assessed in comparison with the standard Holter monitoring and Event Holter
Investigators
Eligibility Criteria
Inclusion Criteria
- •History of symptoms that can be potentially caused by cardiac arrhythmia occuring at least 4 times a year
- •Ability to operate the telemetric device at home
- •Informed consent undersigned by the parents
- •Informed consent undersigned by the child if over 16 years of age
Exclusion Criteria
- •Previously recorded tachycardia evidence
- •Wolff Parkinson White syndrome
- •Inability to operate the telemetric device at home
- •Inability to comply with the study protocol
Outcomes
Primary Outcomes
Recording of symptomatic or life threatening arrhythmia event
Time Frame: within 30 days since the start of monitoring
ECG monitoring is conducted until occurrence of symptomatic arrhythmia or life threatening arrhythmia but not longer than 30 days. Patients in the control group will have standard ECG Holter monitoring repeated twice
Secondary Outcomes
- Occurrence of silent (asymptomatic) arrhythmia event(within 30 days since the start of monitoring)
- Verification of patient self assessment based on the Quality of Life questionnaire and European Heart Rhythm Association (EHRA) scale against evidence of cardiac arrhythmia occurrence(within 30 days since the start of monitoring)